It also needs to be vertically integrated to make money, otherwise it's a handout to the materials science company. I can't see any of the AI companies stretching themselves that thin. So they give it away for goodwill or good PR.
I don't see how OpenAI or Google can profit from drug discovery. It's nearly pure consumer surplus (where the drug companies and patients are the consumers).